Mithun Rudrapal
Overview
Explore the profile of Mithun Rudrapal including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
49
Citations
753
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Altin S, Isik M, Alp C, Dikici E, Koksal E, Kirboga K, et al.
Front Chem
. 2025 Mar;
13:1541250.
PMID: 40046016
Introduction: (LN), has traditional medicinal uses, and this study investigates its therapeutic potential by focusing on its phenolic content and bioactivities such as antioxidant, antidiabetic, and anticholinergic properties. Phenolic compounds...
2.
Kirboga K, Karim A, Kucuksille E, Rudrapal M, Khan J, Achar R, et al.
Front Chem
. 2025 Jan;
12():1515424.
PMID: 39834844
Cannabinoid and stilbenoid compounds derived from were screened against eight specific fungal protein targets to identify potential antifungal agents. The proteins investigated included Glycosylphosphatidylinositol (GPI), Enolase, Mannitol-2-dehydrogenase, GMP synthase, Dihydroorotate...
3.
Mallela V, Rudrapal M, Prasanth D, Pasala P, Bendale A, Bhattacharya S, et al.
Front Chem
. 2024 Dec;
12:1505272.
PMID: 39734578
Lotus seeds, also known as Nelumbinis semen, has been utilized for over 7,000 years as vegetable, functional food and medicine. In this study, we primarily investigated the anticancer effects of...
4.
Bhargav E, Mohammed N, Singh U, Ramalingam P, Challa R, Vallamkonda B, et al.
Heliyon
. 2024 Sep;
10(17):e37430.
PMID: 39296160
This study aimed to enhance the efficacy of quercetin (QT) by formulating it into a liposomal drug delivery system utilizing the concept of central composite design. The drug:lipid ratio, cholesterol...
5.
Tallapalli P, Reddy Y, Yaraguppi D, Matangi S, Challa R, Vallamkonda B, et al.
Pharmaceuticals (Basel)
. 2024 Aug;
17(8).
PMID: 39204198
Objective: This study aimed to compare the effects of β-sitosterol nanoparticles (BETNs) and β-sitosterol (BET) on cognitive impairment, oxidative stress, and inflammation in a myocardial infarction (MI) rat model using...
6.
Rudrapal M, Eltayeb W, Rakshit G, El-Arabey A, Khan J, Aldosari S, et al.
Sci Rep
. 2024 Jul;
14(1):16369.
PMID: 39013973
No abstract available.
7.
Rudrala L, Challa R, Subramanyam S, Ayyappa Gouru S, Singh G, Mulukuri N, et al.
Drug Res (Stuttg)
. 2024 Jul;
74(7):335-346.
PMID: 38991529
Ischemic stroke remains the leading cause of death and disability, while the main mechanisms of dominant neurological damage in stroke contain oxidative stress and inflammation. Docking studies revealed a binding...
8.
Rudrapal M, Rakshit G, Singh R, Garse S, Khan J, Chakraborty S
Antioxidants (Basel)
. 2024 Apr;
13(4).
PMID: 38671877
Polyphenols, as secondary metabolites ubiquitous in plant sources, have emerged as pivotal bioactive compounds with far-reaching implications for human health. Plant polyphenols exhibit direct or indirect associations with biomolecules capable...
9.
Podila N, Penddinti N, Rudrapal M, Rakshit G, Konidala S, Pulusu V, et al.
Heliyon
. 2024 Apr;
10(8):e29390.
PMID: 38655368
In this study, a novel series of pyridine-based thiadiazole derivatives () were synthesized as prospective anti-inflammatory agents by combining substituted carboxylic acid derivatives of 5-substituted-2-amino-1,3,4-thiadiazole with nicotinoyl isothiocyanate in the...
10.
Pasala P, Dsnbk P, Rudrapal M, Challa R, Ahmad S, Vallamkonda B, et al.
Nat Prod Res
. 2024 Apr;
:1-10.
PMID: 38646872
Parkinson's disease (PD) is characterised by the gradual demise of dopaminergic neurons. In recent years, there has been significant interest in herbal treatments. In this study, hesperetin nanoparticles (HTN) were...